Novo Holdings A/S Long-Term Concentrated

Location: Hellerup, Denmark

CIK: 0001388325 · Show all filings

Period: Q1 2015 (← Previous) (Next →)

Filing Date: May 15, 2015

Total Value: $1.176B (98.3% shares, 1.7% debt)

Holdings (14)

VTI VANGUARD INDEX FDS 27.2%

Value $320M Shares 2,979,100 Share Price $107.25 Est. Cost/Share $57.39 Unrealized @ Report Date —

— OPHTHOTECH CORP 19.4%

Value $228M Shares 4,910,487 Share Price $46.53 Est. Cost/Share $32.35 Unrealized @ Report Date —

VGK VANGUARD INTL EQUITY INDEX F 9.7%

Value $114M Shares 2,101,000 Share Price $54.22 Est. Cost/Share $45.01 Unrealized @ Report Date —

INGN INOGEN INC 9.7%

Value $114M Shares 3,549,320 Share Price $31.99 Est. Cost/Share $17.78 Unrealized @ Report Date +81.5%

— NEVRO CORP 8.9%

Value $105M Shares 2,194,841 Share Price $47.93 Est. Cost/Share $38.67 Unrealized @ Report Date —

— ALDER BIOPHARMACEUTICALS INC 7.9%

Value $92.39M Shares 3,201,183 Share Price $28.86 Est. Cost/Share $20.07 Unrealized @ Report Date —

— OTONOMY INC 6.5%

Value $76.91M Shares 2,175,025 Share Price $35.36 Est. Cost/Share $24.00 Unrealized @ Report Date —

— FLEXION THERAPEUTICS INC 4.4%

Value $51.42M Shares 2,283,131 Share Price $22.52 Est. Cost/Share $17.27 Unrealized @ Report Date —

— WRIGHT MED GROUP INC 1.7%

Value $20.3M Shares 4,720,065 Share Price $4.30 Est. Cost/Share $2.50 Unrealized @ Report Date —

AKBA AKEBIA THERAPEUTICS INC 1.4%

Value $16.85M Shares 1,516,387 Share Price $11.11 * Est. Cost/Share $24.08 Unrealized @ Report Date -55.8%

— TOKAI PHARMACEUTICALS INC 1.1%

Value $13.38M Shares 1,184,196 Share Price $11.30 Est. Cost/Share $14.46 Unrealized @ Report Date —

— AERIE PHARMACEUTICALS INC 1.1%

Value $13.15M Shares 419,652 Share Price $31.34 Est. Cost/Share $29.19 Unrealized @ Report Date —

— TETRAPHASE PHARMACEUTICALS INC 0.7%

Value $8.479M Shares 231,419 Share Price $36.64 Est. Cost/Share $23.73 Unrealized @ Report Date —

XENE XENON PHARMACEUTICALS INC 0.2%

Value $2.151M Shares 127,563 Share Price $16.86 * Est. Cost/Share $14.68 Unrealized @ Report Date +25.8%

Ticker	Issuer	Shares	Value	%	Share Price	Est. Cost/Share	Unrealized @ Report Date	Class	CUSIP
VTI	VANGUARD INDEX FDS	2,979,100	$320M	27.2%	$107.25	$57.39	—	TOTAL STK MKT	922908769
—	OPHTHOTECH CORP	4,910,487	$228M	19.4%	$46.53	$32.35	—	COM	683745103
VGK	VANGUARD INTL EQUITY INDEX F	2,101,000	$114M	9.7%	$54.22	$45.01	—	FTSE EUROPE ETF	922042874
INGN	INOGEN INC	3,549,320	$114M	9.7%	$31.99	$17.78	+81.5%	COM	45780L104
—	NEVRO CORP	2,194,841	$105M	8.9%	$47.93	$38.67	—	COM	64157F103
—	ALDER BIOPHARMACEUTICALS INC	3,201,183	$92.39M	7.9%	$28.86	$20.07	—	COM	014339105
—	OTONOMY INC	2,175,025	$76.91M	6.5%	$35.36	$24.00	—	COM	68906L105
—	FLEXION THERAPEUTICS INC	2,283,131	$51.42M	4.4%	$22.52	$17.27	—	COM	33938J106
—	WRIGHT MED GROUP INC	4,720,065	$20.3M	1.7%	$4.30	$2.50	—	RIGHT 03/01/2019	98235T115
AKBA	AKEBIA THERAPEUTICS INC	1,516,387	$16.85M	1.4%	$11.11 *	$24.08	-55.8%	COM	00972D105
—	TOKAI PHARMACEUTICALS INC	1,184,196	$13.38M	1.1%	$11.30	$14.46	—	COM	88907J107
—	AERIE PHARMACEUTICALS INC	419,652	$13.15M	1.1%	$31.34	$29.19	—	COM	00771V108
—	TETRAPHASE PHARMACEUTICALS INC	231,419	$8.479M	0.7%	$36.64	$23.73	—	COM	88165N105
XENE	XENON PHARMACEUTICALS INC	127,563	$2.151M	0.2%	$16.86 *	$14.68	+25.8%	COM	98420N105